✦ LIBER ✦

6576 POSTER Phase II Safety Study of the Oral Multikinase Inhibitor Regorafenib (BAY 73-4506) as Second-line Therapy in Patients With Hepatocellular Carcinoma

✍ Scribed by Bolondi, L.; Tak, W.Y.; Gasbarrini, A.; Santoro, A.; Colombo, M.; Lim, H.Y.; Mazzaferro, V.; Wiest, R.; Reig, M.; Bruix, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7141 POSTER Phase II Trial of the Oral M

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

1236 POSTER Phase I Study to Assess the

✍ J. Furuse; Y. Sasaki; T. Okusaka; M. Ikeda; F. Nagashima; Y. Sunakawa; H. Ueno; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

7105 Phase II trial of the oral multikin

✍ Eisen, T.; Joensuu, H.; Nathan, P.; Harper, P.; Wojtukiewicz, M.; Nicholson, S.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB